The only class of drugs showing cytotoxicity patterns that correlated with ABC-/GCB-DLBCL subtype was the AKT inhibitors ipatasertib and GSK690693, which selectively killed cell lines of the GCB-, but not the ABC-DLBCL subtype (Fig. 1b, c). Here, ABCB6 is linked to diffuse large B-cell lymphoma.